Wiley Handbook of Current and Emerging Drug Therapies

  • Ritter J
N/ACitations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Provides the latest information on new molecular entities, clinical trials, drug approvals, and post-approval studies of new drugs. Vol. 1. Part I: Introduction -- Part II: Oncology -- Vol. 2. Part II: Oncology -- Part III: Immune system -- Vol. 3. Part IV: Metabolic diseases -- Part V: Infectious diseases -- Vol. 4. Part VI: Emerging technologies and business opportunities -- Part VII: Global markets and national policy -- Part VIII: New opportunities in drug discovery and pipeline development -- Vol. 5. Part IX: Metabolic diseases -- Part X: Infectious diseases -- Part XI: Central nervous system -- Vol. 6. Part XI: Central nervous system -- Part XII: Opthalmologic -- Part XIII: Cardiology -- Vol. 7. Part XIII: Cardiology -- Part XIV: Genitourinary -- Part XV: Pain treatment -- Part XVI: Respiratory -- Part XVII: Gastrointestinal -- Part XVIII: Major issues in pharmaceutical R & D -- Part XIX: Global markets and national policy -- Part XX: Technological advances and business opportunities.

Cite

CITATION STYLE

APA

Ritter, J. M. (2008). Wiley Handbook of Current and Emerging Drug Therapies. British Journal of Clinical Pharmacology, 65(3), 449–449. https://doi.org/10.1111/j.1365-2125.2007.03054.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free